Indivi is an ISO 13485 and ISO 27001-certified TechBio company headquartered in Basel (Switzerland) and developing future-proof functional biomarkers derived from DHT tools measuring key disability concepts of importance for drug development trials in neuroscience therapeutic areas, e.g. multiple sclerosis, Parkinson's disease and other alpha-synucleinopathies, Alzheimer's disease and related dementias, muscular dystrophies and neuromuscular disorders.
Leadership & Board
Current Number of Employees79
Current LinkedIn Followers5,829
Latest Estimated Valuation
Estimated Valuation―
Estimated Valuation―
Total Amount Raised$15M
Total Amount Raised$15M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$15M
Latest Funding Amount$15M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation―
Post-Money Valuation―
Employee Trend
Indivi had 79 employees as of September 7, 2026. The number of employees increased by 0 (0.00%) week-over-week.
79Latest Employee Count
0(0.00%)Week-Over-Week Change
Employee Trend serves as a data-driven indicator of company growth and expansion. The measurement reflects how a company’s workforce size changes over time.
Social Trend
Indivi had 5,829 followers as of September 7, 2026. The number of followers increased by 7 (0.12%) week-over-week.
5,829Latest Followers Count
7(0.12%)Week-Over-Week Change
LinkedIn Follower Trend serves as a data-driven indicator of market interest and company visibility. The measurement reflects how a company’s LinkedIn follower count changes over time.